At a glance
ClinicalIndex Comparison RecordN/ACompleted· 84 enrolled
Drug / intervention
Brief LEV +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Short Duration Levetiracetam to Extended Course Levetiracetam for Seizure Prophylaxis Following Subarachnoid Hemorrhage
In Brief
A clinical study evaluating Brief LEV and Extended LEV for Subarachnoid Hemorrhage. Completed, enrolled 84 participants across 1 site.
Detailed Summary
Our primary objective is to compare two treatment options for prevention of seizures following a subarachnoid hemorrhage and determine if a short-course regimen of levetiracetam is as efficacious in the prevention of in-hospital seizures when compared to an extended course.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubarachnoid Hemorrhage
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2010
First PostedJun 2010
Primary CompletionJan 2013
Study CompletionJan 2017
TodayJul 2026
First PostedJun 4, 2010
Enrollment StartMay 1, 2010
Primary CompletionJan 1, 2013
Study CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 16.1 years ago
Interventions
Brief LEVother
Levetiracetam 1000mg BID x 3 days for prophylaxis
Extended LEVother
Levetiracetam 1000mg BID for length of hospital stay for prophylaxis